Pacira BioSciences, Inc.

NasdaqGS:PCRX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

💊 Pharmaceuticals

💻 Telehealth

Location

United States

Market Cap

USD 1.12 B

Share Price

USD 24.23

Avg Daily Volume

899,133

Change (1 day)

0.33%

Change (1 year)

-13.46%

Change (YTD)

28.61%

Pacira BioSciences, Inc. Market Capitalization on June 20, 2025: USD 1.12 B

Pacira BioSciences, Inc. Market Capitalization is USD 1.12 B on June 20, 2025, a -13.90% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Pacira BioSciences, Inc. 52-week low Market Capitalization is USD 1.35 B on June 20, 2025, which is 20.50% above the current Market Capitalization.
Pacira BioSciences, Inc. 52-week low Market Capitalization is USD 540.69 M on June 20, 2025, which is -51.81% below the current Market Capitalization.
Pacira BioSciences, Inc. average Market Capitalization for the last 52 weeks is USD 969.53 M.

Daily

From:

To:

Zoom:

Key data

Date	Market Capitalization	Share Price	Share Price	Price to Earnings Ratio (P/E)

NasdaqGS: PCRX

Pacira BioSciences, Inc.

CEO	Mr. Frank D. Lee
IPO Date	Feb. 3, 2011
Location	United States
Headquarters	5401 West Kennedy Boulevard
Employees	788
Sector	🏥 Health Care
Industries Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 💊 Pharmaceuticals 💻 Telehealth

Description

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.